BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 29 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 500,000 | $1,881,000 | 0.06% |
| AJU IB Investment Co., Ltd. | 25,651 | $96,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $199,000 | 0.01% |
| Baker Brothers Advisors | 249,123 | $937,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $49,000 | 0.00% |
| Squarepoint Ops LLC | 27,915 | $105,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $23,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 13,300 | $50,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26 | $0 | 0.00% |